Berberine as a therapy for type 2 diabetes and its complications: From mechanism of action to clinical studies.
about
Immune Cell Regulatory Pathways Unexplored as Host-Directed Therapeutic Targets for Mycobacterium tuberculosis: An Opportunity to Apply Precision Medicine Innovations to Infectious DiseasesBerberine Attenuates Development of the Hepatic Gluconeogenesis and Lipid Metabolism Disorder in Type 2 Diabetic Mice and in Palmitate-Incubated HepG2 Cells through Suppression of the HNF-4α miR122 PathwayBerberine alleviates the cerebrovascular contractility in streptozotocin-induced diabetic rats through modulation of intracellular Ca²⁺ handling in smooth muscle cells.Factors Influencing the Gut Microbiota, Inflammation, and Type 2 Diabetes.Renoprotective effects of berberine as adjuvant therapy for hypertensive patients with type 2 diabetes mellitus: Evaluation via biochemical markers and color Doppler ultrasonography.The Compound of Mangiferin-Berberine Salt Has Potent Activities in Modulating Lipid and Glucose Metabolisms in HepG2 Cells.Could hop-derived bitter compounds improve glucose homeostasis by stimulating the secretion of GLP-1?Berberis integerrima ameliorates insulin resistance in high- fructose-fed insulin-resistant rats.Effects of type 2 diabetes mellitus on the pharmacokinetics of berberine in rats.Composition and diversity of rhizosphere fungal community in Coptis chinensis Franch. continuous cropping fields.
P2860
Q28081001-A984F35C-0985-4325-8FE2-F671E6FD84C3Q28550972-60826ED3-72EF-4B6B-8782-CC8F6990189AQ36790209-76360430-D3BA-4089-AEE4-4C2A71DD8C1FQ39374045-C994ECCC-B686-4629-8355-A24C92153442Q42434705-2F68FF49-2155-451B-8DEB-3371F5DCCE91Q42492483-BB18A8A2-977A-47EA-B743-2B01EE3E7172Q46307017-F7C88D94-DB8A-449C-A099-128981A55EF2Q47139281-CCB4E69F-1551-47B0-A1CF-70E047288F65Q51019283-032F89AA-E92F-4FF3-8FA5-B6F122E78764Q55017149-3F520026-24E3-4F02-8DA4-C0AD99B513A8
P2860
Berberine as a therapy for type 2 diabetes and its complications: From mechanism of action to clinical studies.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Berberine as a therapy for typ ...... of action to clinical studies.
@en
type
label
Berberine as a therapy for typ ...... of action to clinical studies.
@en
prefLabel
Berberine as a therapy for typ ...... of action to clinical studies.
@en
P2093
P2860
P356
P1476
Berberine as a therapy for typ ...... of action to clinical studies.
@en
P2093
Grant M Hatch
Wenguang Chang
P2860
P304
P356
10.1139/BCB-2014-0107
P577
2014-12-01T00:00:00Z